Form 4 for ONC BeOne Medicines Ltd.
Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-10 · accession 0000899243-21-035731 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-13 | 2021-09-10 | ONC | AMGEN INC | 10% | P - Purchase | $302.06 | +165.5K | 18.94M | +0.9% | +$50.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2021-09-10 | P | A | 165,529 | $302.06 | 18,943,802 | D | — | — | (F1) This transaction was made pursuant to that Share Purchase Agreement, dated as of September 24, 2020, as amended, by and between the Reporting Person and the Issuer. (F2) The price reported is the volume weighted average price on the NASDAQ Stock Market LLC of one American Depositary Share ("ADS") of the Issuer for the ninety calendar days preceding August 31, 2021. (F3) As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 246,269,426 Ordinary Shares. |